Bill & Melinda Gates Foundation and Wellcome pledge $300 million to CEPI for COVID-19 pandemic response
The foundations call on world leaders to support the Coalition for Epidemic Preparedness Innovations (CEPI) to help end the COVID-19 crisis, prepare for future pandemics, and address epidemic threats...
January 21, 2022
by ExpressPharma
Bill & Melinda Gates Foundation and Wellcome Pledge US$300 Million to CEPI for COVID-19 Pandemic Response and to Accelerate Epidemic Preparedness
Today the Bill & Melinda Gates Foundation and Wellcome each pledged US$150 million for a total of US$300 million to the Coalition for Epidemic Preparedness Innovations (CEPI)...
January 19, 2022
by prnasia
Gritstone bio and CEPI extend deal to develop Omicron vaccine candidate
Gritstone bio and the Coalition for Epidemic Preparedness Innovations (CEPI) have expanded their agreement to develop a self-amplifying mRNA (SAM) vaccine against the Omicron variant of the SARS-CoV-2 virus.
December 8, 2021
by Pharmaceutical-Technology
‘Marketplace’ launched to speed up global access to COVID-19 vaccine
CEPI has launched COVAX Marketplace to accelerate the global production of COVID-19 vaccines, increasing access to doses.
July 21, 2021
by europeanpharmaceuticalreview
CEPI and VBI to develop vaccines against SARS-CoV-2 variants
The Coalition for Epidemic Preparedness Innovations (CEPI) and VBI Vaccines have entered a collaboration to advance the latter’s enveloped virus-like particle (eVLP) vaccine candidates against SARS-CoV-2 variants.
March 12, 2021
by pharmaceutical-technology
CEPI plans 100-day target for new vaccines against emerging disease epidemics
Compressing vaccine development timelines to 100 days would make them around a third as long as it took the world to develop the first COVID-19 vaccines, CEPI said.
March 11, 2021
by expresspharma
CEPI offers $140 million to support research on COVID-19 vaccines
CEPI has opened a new funding opportunity, providing up to $140 million to support additional clinical research on COVID-19 vaccines.
February 1, 2021
by europeanpharmaceuticalreview
Dr Harsh Vardhan inaugurates CEPI centralised network lab at DBT-THSTI Faridabad virtually
The CEPI laboratory will be a great addition to the ability of THSTI to enhance the quality of services towards making vaccine and acceptability at global level, said Dr Harsh Vardhan.
January 6, 2021
by expresspharma
CEPI to help advance development and manufacture of COVID-19 vaccine from Biological E
The Coalition for Epidemic Preparedness Innovations (CEPI) and Biological E, India announced a collaboration to advance the development and manufacture of Biological E’s COVID-19 subunit vaccine candidate.
December 30, 2020
by expresspharma
COVAX Alliance secures two billion doses of COVID-19 vaccines
It aims to deliver 1.3 billion doses of approved vaccines next year to 92 eligible low- and middle-income economies.
December 21, 2020
by expresspharma
CEPI to fund Clover’s Covid-19 vaccine development
The Coalition for Epidemic Preparedness Innovations (CEPI) has extended its partnership to fund the development of Sichuan Clover Biopharmaceuticals’ protein-based S-Trimer Covid-19 vaccine candidate.
November 6, 2020
by pharmaceutical-technology
CEPI extends partnership with Clover Biopharma to fund COVID-19 vaccine candidate
CEPI to fund the development of Clover’s protein-based S-Trimer vaccine candidate through to licensure, including a global pivotal Phase 2/3 efficacy clinical study beginning before the end of 2020.
November 4, 2020
by expresspharma